Gene: CAMK2B (calcium/calmodulin dependent protein kinase II beta) Homo sapiens
Analyze
Symbol:
CAMK2B
Name:
calcium/calmodulin dependent protein kinase II beta
Description:
Exhibits protein homodimerization activity. Involved in protein autophosphorylation and regulation of neuron migration. Localizes to the calcium- and calmodulin-dependent protein kinase complex. Implicated in autosomal dominant mental retardation 54.
Type:
protein-coding
RefSeq Status:
REVIEWED
Also known as:
calcium/calmodulin-dependent protein kinase (CaM kinase) II beta; calcium/calmodulin-dependent protein kinase II beta; calcium/calmodulin-dependent protein kinase ii beta subunit; calcium/calmodulin-dependent protein kinase type II beta chain; calcium/calmodulin-dependent protein kinase type II subunit beta; CaM kinase II beta subunit; caM kinase II subunit beta; CaM-kinase II beta chain; CAM2; caMK-II subunit beta; CAMK2; CAMKB; CaMKIIbeta; MGC29528; MRD54; proline rich calmodulin-dependent protein kinase
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Mus musculus (house mouse):
Camk2b (calcium/calmodulin-dependent protein kinase II, beta) HGNC
Ensembl, HGNC, HomoloGene, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Rattus norvegicus (Norway rat):
Camk2b (calcium/calmodulin-dependent protein kinase II beta) HGNC
Ensembl, HomoloGene, NCBI, Panther
Chinchilla lanigera (long-tailed chinchilla):
Camk2b (calcium/calmodulin dependent protein kinase II beta) NCBI
Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):
CAMK2B (calcium/calmodulin dependent protein kinase II beta) NCBI
Ortholog
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Camk2b (calcium/calmodulin dependent protein kinase II beta) NCBI
Ortholog
Sus scrofa (pig):
CAMK2B (calcium/calmodulin dependent protein kinase II beta) HGNC
Ensembl, NCBI, OrthoDB
Other homologs 2
Canis lupus familiaris (dog):
CAMK2G (calcium/calmodulin dependent protein kinase II gamma) HGNC
Inparanoid, OrthoDB
Mus musculus (house mouse):
Camk2g (calcium/calmodulin-dependent protein kinase II gamma) HGNC
OrthoDB, OrthoMCL
Rattus norvegicus (Norway rat):
Camk2a (calcium/calmodulin-dependent protein kinase II alpha) HGNC
OrthoDB
Rattus norvegicus (Norway rat):
Camk2d (calcium/calmodulin-dependent protein kinase II delta) HGNC
OrthoDB
Mus musculus (house mouse):
Camk2a (calcium/calmodulin-dependent protein kinase II alpha) HGNC
OrthoDB
Rattus norvegicus (Norway rat):
Camk2g (calcium/calmodulin-dependent protein kinase II gamma) HGNC
OrthoDB
Mus musculus (house mouse):
Camk2d (calcium/calmodulin-dependent protein kinase II, delta) HGNC
OrthoDB
Canis lupus familiaris (dog):
CAMK2A (calcium/calmodulin dependent protein kinase II alpha) HGNC
OrthoDB
Canis lupus familiaris (dog):
CAMK2D (calcium/calmodulin dependent protein kinase II delta) HGNC
OrthoDB
Sus scrofa (pig):
CAMK2A (calcium/calmodulin dependent protein kinase II alpha) HGNC
OrthoDB
Sus scrofa (pig):
CAMK2G (calcium/calmodulin dependent protein kinase II gamma) HGNC
OrthoDB
Sus scrofa (pig):
CAMK2D (calcium/calmodulin dependent protein kinase II delta) HGNC
OrthoDB
Canis lupus familiaris (dog):
CAMK2B (calcium/calmodulin dependent protein kinase II beta) HGNC
NCBI
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Camk2b (calcium/calmodulin-dependent protein kinase II beta)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, OMA, OrthoFinder, PANTHER, PhylomeDB)
Mus musculus (house mouse):
Camk2b (calcium/calmodulin-dependent protein kinase II, beta)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, Roundup, TreeFam)
Danio rerio (zebrafish):
camk2b1 (calcium/calmodulin-dependent protein kinase (CaM kinase) II beta 1)
Alliance
DIOPT (Ensembl Compara, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, Roundup, TreeFam, ZFIN)
Drosophila melanogaster (fruit fly):
CaMKII
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, PANTHER, PhylomeDB, Roundup, TreeFam)
Caenorhabditis elegans (roundworm):
unc-43
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, PANTHER, PhylomeDB, Roundup, TreeFam)
Allele / Splice:
See ClinVar data
Latest Assembly:
GRCh38 - Human Genome Assembly GRCh38
Position:
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 Ensembl 7 44,217,150 - 44,334,577 (-) Ensembl GRCh38 7 44,217,150 - 44,326,167 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh37 7 44,256,749 - 44,365,230 (-) ENTREZGENE GRCh37 GRCh37 hg19 GRCh37 Build 36 7 44,225,416 - 44,331,749 (-) NCBI NCBI36 hg18 NCBI36 Build 34 7 44,032,136 - 44,138,464 NCBI Celera 7 44,354,715 - 44,422,313 (-) NCBI Cytogenetic Map 7 p13 NCBI HuRef 7 44,142,028 - 44,208,379 (-) ENTREZGENE HuRef CHM1_1 7 44,260,608 - 44,369,178 (-) NCBI CHM1_1 CRA_TCAGchr7v2 7 44,296,255 - 44,404,749 (-) ENTREZGENE
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Disease Annotations
Imported Annotations - ClinVar
autosomal dominant mental retardation 54 IAGP RGD:13504204 8554872 ClinVar Annotator: match by term: MENTAL RETARDATION, AUTOSOMAL DOMINANT 54 ClinVar PMID:29100089 autosomal dominant mental retardation 54 IAGP RGD:13784415 8554872 ClinVar Annotator: match by term: MENTAL RETARDATION, AUTOSOMAL DOMINANT 54 ClinVar PMID:29560374 autosomal dominant mental retardation 54 IAGP RGD:13784417 8554872 ClinVar Annotator: match by term: MENTAL RETARDATION, AUTOSOMAL DOMINANT 54 ClinVar PMID:29560374 autosomal dominant mental retardation 54 IAGP RGD:13476692 8554872 ClinVar Annotator: match by term: MENTAL RETARDATION, AUTOSOMAL DOMINANT 54 ClinVar PMID:11994750 more ... autosomal dominant mental retardation 54 IAGP RGD:13476696 8554872 ClinVar Annotator: match by term: MENTAL RETARDATION, AUTOSOMAL DOMINANT 54 ClinVar PMID:11994750 more ... autosomal dominant mental retardation 54 IAGP RGD:13476682 8554872 ClinVar Annotator: match by term: MENTAL RETARDATION, AUTOSOMAL DOMINANT 54 ClinVar PMID:29100089 autosomal dominant mental retardation 54 IAGP RGD:13476688 8554872 ClinVar Annotator: match by term: MENTAL RETARDATION, AUTOSOMAL DOMINANT 54 ClinVar PMID:29100089 genetic disease IAGP RGD:13476696 8554872 ClinVar Annotator: match by term: Inborn genetic diseases ClinVar PMID:11994750 more ... genetic disease IAGP RGD:13476692 8554872 ClinVar Annotator: match by term: Inborn genetic diseases ClinVar PMID:11994750 more ... intellectual disability IAGP RGD:13506484 8554872 ClinVar Annotator: match by term: Intellectual disability ClinVar PMID:29100089 intellectual disability IAGP RGD:13476692 8554872 ClinVar Annotator: match by term: Intellectual disability ClinVar PMID:11994750 more ... intellectual disability IAGP RGD:13476696 8554872 ClinVar Annotator: match by term: Intellectual disability ClinVar PMID:11994750 more ... intellectual disability IAGP RGD:13476682 8554872 ClinVar Annotator: match by term: Intellectual disability ClinVar PMID:29100089 intellectual disability IAGP RGD:13476688 8554872 ClinVar Annotator: match by term: Intellectual disability ClinVar PMID:29100089 intellectual disability IAGP RGD:13506458 8554872 ClinVar Annotator: match by term: Intellectual disability ClinVar PMID:29100089 intellectual disability IAGP RGD:13504204 8554872 ClinVar Annotator: match by term: Intellectual disability ClinVar PMID:29100089 pleomorphic xanthoastrocytoma IAGP RGD:12859021 8554872 ClinVar Annotator: match by term: Pleomorphic xanthoastrocytoma ClinVar PMID:28299358
Imported Annotations - CTD
cannabis abuse EXP 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:17205118 Cocaine-Related Disorders EXP 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:17205118 phencyclidine abuse EXP 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:17205118 schizophrenia EXP 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:11042361 , PMID:20336626 substance-induced psychosis EXP 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:17603807 Imported Annotations - OMIM
autosomal dominant mental retardation 54 IAGP 7240710 OMIM
(S)-amphetamine increases expression ISO RGD:2262 6480464 Dextroamphetamine results in increased expression of CAMK2B mRNA CTD PMID:17603807 17alpha-ethynylestradiol increases expression ISO RGD:10285 6480464 Ethinyl Estradiol results in increased expression of CAMK2B mRNA CTD PMID:17942748 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of CAMK2B mRNA CTD PMID:30165855 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:10285 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:10285 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10285 6480464 Tetrachlorodibenzodioxin affects the expression of CAMK2B mRNA CTD PMID:21570461 2,4,6-trinitrobenzenesulfonic acid decreases expression ISO RGD:2262 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of CAMK2B mRNA CTD PMID:23537331 3-methylcholanthrene multiple interactions ISO RGD:10285 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CAMK2B mRNA CTD PMID:23519560 4,4'-diaminodiphenylmethane decreases expression ISO RGD:10285 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of CAMK2B mRNA CTD PMID:18648102 4-[1-hydroxy-2-[4-(phenylmethyl)-1-piperidinyl]propyl]phenol multiple interactions ISO RGD:2262 6480464 ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein] CTD PMID:24718106 acrylamide decreases expression ISO RGD:2262 6480464 Acrylamide results in decreased expression of CAMK2B mRNA CTD PMID:28959563 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CAMK2B mRNA CTD PMID:22100608 aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of CAMK2B intron CTD PMID:30157460 aflatoxin B2 affects methylation EXP 6480464 aflatoxin B2 affects the methylation of CAMK2B intron CTD PMID:30157460 all-trans-retinoic acid multiple interactions ISO RGD:2262 6480464 CAMK2B protein promotes the reaction [Tretinoin results in increased phosphorylation of MAPK1 protein], CAMK2B protein promotes the reaction [Tretinoin results in increased phosphorylation of MAPK3 protein] CTD PMID:19635392 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of CAMK2B mRNA CTD PMID:23724009 ammonium chloride affects expression ISO RGD:2262 6480464 Ammonium Chloride affects the expression of CAMK2B mRNA CTD PMID:16483693 androgen antagonist multiple interactions ISO RGD:2262 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CAMK2B mRNA CTD PMID:25607892 arsane affects methylation EXP 6480464 Arsenic affects the methylation of CAMK2B gene CTD PMID:25304211 arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of CAMK2B gene CTD PMID:25304211 azamethiphos multiple interactions ISO RGD:2262 6480464 azamethiphos promotes the reaction [NGF protein results in increased expression of CAMK2B mRNA] CTD PMID:28385489 benzo[a]pyrene increases mutagenesis EXP 6480464 Benzo(a)pyrene results in increased mutagenesis of CAMK2B gene CTD PMID:25435355 benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of CAMK2B intron CTD PMID:30157460 benzo[a]pyrene multiple interactions ISO RGD:10285 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to CAMK2B promoter] CTD PMID:19654925 benzo[a]pyrene decreases expression ISO RGD:10285 6480464 Benzo(a)pyrene results in decreased expression of CAMK2B mRNA CTD PMID:19770486 benzo[e]pyrene increases methylation EXP 6480464 benzo(e)pyrene results in increased methylation of CAMK2B intron CTD PMID:30157460 bis(2-chloroethyl) sulfide increases expression ISO RGD:10285 6480464 Mustard Gas results in increased expression of CAMK2B mRNA CTD PMID:15674844 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:2262 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA CTD PMID:25607892 bisphenol A multiple interactions ISO RGD:2262 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CAMK2B mRNA, [bisphenol A co-treated with tributyltin] results in increased expression of CAMK2B mRNA CTD PMID:25607892 , PMID:31129395 bisphenol A increases methylation ISO RGD:2262 6480464 bisphenol A results in increased methylation of CAMK2B gene CTD PMID:28505145 bisphenol A decreases expression ISO RGD:2262 6480464 bisphenol A results in decreased expression of CAMK2B mRNA CTD PMID:25181051 butan-1-ol multiple interactions EXP 6480464 [[Gasoline co-treated with 1-Butanol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CAMK2B mRNA CTD PMID:29432896 carbon dioxide multiple interactions ISO RGD:2262 6480464 [Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein more ... CTD PMID:24718106 carbon nanotube increases expression ISO RGD:10285 6480464 Nanotubes, Carbon analog results in increased expression of CAMK2B mRNA, Nanotubes, Carbon results in increased expression of CAMK2B mRNA CTD PMID:25620056 chlorpyrifos increases expression ISO RGD:10285 6480464 Chlorpyrifos results in increased expression of CAMK2B mRNA CTD PMID:20350560 chlorpyrifos multiple interactions ISO RGD:2262 6480464 Chlorpyrifos promotes the reaction [NGF protein results in increased expression of CAMK2B mRNA] CTD PMID:28385489 choline affects expression ISO RGD:2262 6480464 Choline affects the expression of CAMK2B mRNA, Choline affects the expression of CAMK2B protein CTD PMID:17264169 ciguatoxin CTX1B affects expression ISO RGD:10285 6480464 Ciguatoxins affects the expression of CAMK2B mRNA CTD PMID:18353800 cisplatin multiple interactions ISO RGD:2262 6480464 trichostatin A inhibits the reaction [Cisplatin results in decreased expression of CAMK2B mRNA] CTD PMID:23558232 cisplatin decreases expression ISO RGD:2262 6480464 Cisplatin results in decreased expression of CAMK2B mRNA CTD PMID:23558232 clozapine decreases expression ISO RGD:2262 6480464 Clozapine results in decreased expression of CAMK2B mRNA CTD PMID:15860345 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of CAMK2B mRNA CTD PMID:17205118 cocaine affects expression ISO RGD:2262 6480464 Cocaine affects the expression of CAMK2B mRNA CTD PMID:20187946 cyhalothrin multiple interactions ISO RGD:2262 6480464 cyhalothrin promotes the reaction [NGF protein results in increased expression of CAMK2B mRNA] CTD PMID:28385489 DDE multiple interactions ISO RGD:2262 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA CTD PMID:25607892 dibutyl phthalate decreases expression ISO RGD:2262 6480464 Dibutyl Phthalate results in decreased expression of CAMK2B mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions ISO RGD:2262 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA CTD PMID:25607892 diclofenac increases expression ISO RGD:2262 6480464 Diclofenac results in increased expression of CAMK2B mRNA CTD PMID:30723492 dieldrin affects expression ISO RGD:2262 6480464 Dieldrin affects the expression of CAMK2B mRNA CTD PMID:22546817 diethylstilbestrol increases expression ISO RGD:10285 6480464 Diethylstilbestrol results in increased expression of CAMK2B protein modified form CTD PMID:20433902 dioxygen multiple interactions ISO RGD:2262 6480464 [Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein more ... CTD PMID:24718106 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of CAMK2B mRNA CTD PMID:26516004 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of CAMK2B mRNA CTD PMID:29803840 elemental selenium increases expression EXP 6480464 Selenium results in increased expression of CAMK2B mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CAMK2B mRNA CTD PMID:26615145 enzacamene multiple interactions ISO RGD:2262 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CAMK2B mRNA CTD PMID:25607892 epoxiconazole multiple interactions ISO RGD:2262 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA CTD PMID:25607892 ethanol decreases expression ISO RGD:2262 6480464 Ethanol results in decreased expression of CAMK2B mRNA CTD PMID:20655511 ethanol multiple interactions ISO RGD:10285 6480464 Ethanol affects the expression of and affects the splicing of CAMK2B mRNA CTD PMID:30319688 ethanol multiple interactions EXP 6480464 [[Gasoline co-treated with Ethanol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CAMK2B mRNA CTD PMID:29432896 ferroheme b decreases expression ISO RGD:10285 6480464 Heme metabolite results in decreased expression of CAMK2B mRNA CTD PMID:19191707 furan increases expression ISO RGD:2262 6480464 furan results in increased expression of CAMK2B mRNA CTD PMID:22079235 haloperidol decreases expression ISO RGD:2262 6480464 Haloperidol results in decreased expression of CAMK2B mRNA CTD PMID:15860345 heme b decreases expression ISO RGD:10285 6480464 Heme metabolite results in decreased expression of CAMK2B mRNA CTD PMID:19191707 isoprenaline increases expression ISO RGD:10285 6480464 Isoproterenol results in increased expression of CAMK2B mRNA CTD PMID:20003209 lead(0) affects expression EXP 6480464 Lead affects the expression of CAMK2B mRNA CTD PMID:28903495 lead(2+) affects expression EXP 6480464 Lead affects the expression of CAMK2B mRNA CTD PMID:28903495 linuron multiple interactions ISO RGD:2262 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA CTD PMID:25607892 lovastatin multiple interactions ISO RGD:2262 6480464 Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein] CTD PMID:24718106 malathion multiple interactions ISO RGD:2262 6480464 Malathion promotes the reaction [NGF protein results in increased expression of CAMK2B mRNA] CTD PMID:28385489 methapyrilene increases methylation EXP 6480464 Methapyrilene results in increased methylation of CAMK2B intron CTD PMID:30157460 nickel dichloride affects expression ISO RGD:2262 6480464 nickel chloride affects the expression of CAMK2B mRNA CTD PMID:22546817 ochratoxin A increases expression ISO RGD:2262 6480464 ochratoxin A results in increased expression of CAMK2B mRNA CTD PMID:23358140 paclitaxel affects response to substance EXP 6480464 CAMK2B protein affects the susceptibility to Paclitaxel CTD PMID:16217747 paracetamol affects expression ISO RGD:10285 6480464 Acetaminophen affects the expression of CAMK2B mRNA CTD PMID:17562736 paracetamol multiple interactions ISO RGD:2262 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CAMK2B mRNA CTD PMID:25607892 phencyclidine decreases expression EXP 6480464 Phencyclidine results in decreased expression of CAMK2B mRNA CTD PMID:17205118 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:10285 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CAMK2B mRNA CTD PMID:23519560 pirinixic acid increases expression ISO RGD:10285 6480464 pirinixic acid results in increased expression of CAMK2B mRNA CTD PMID:18445702 prochloraz multiple interactions ISO RGD:2262 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA CTD PMID:25607892 procymidone multiple interactions ISO RGD:2262 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA CTD PMID:25607892 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of CAMK2B mRNA CTD PMID:21540246 propiconazole increases expression ISO RGD:10285 6480464 propiconazole results in increased expression of CAMK2B mRNA CTD PMID:21278054 quercitrin decreases expression EXP 6480464 quercitrin results in decreased expression of CAMK2B mRNA CTD PMID:25193878 rotenone affects expression ISO RGD:10285 6480464 Rotenone affects the expression of CAMK2B mRNA CTD PMID:23186747 selenium atom increases expression EXP 6480464 Selenium results in increased expression of CAMK2B mRNA CTD PMID:19244175 Soman decreases expression ISO RGD:2262 6480464 Soman results in decreased expression of CAMK2B mRNA CTD PMID:19281266 sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of CAMK2B mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:10285 6480464 Tamoxifen affects the expression of CAMK2B mRNA CTD PMID:20937368 titanium dioxide decreases expression ISO RGD:10285 6480464 titanium dioxide results in decreased expression of CAMK2B mRNA CTD PMID:23557971 triazines multiple interactions ISO RGD:10285 6480464 Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of CAMK2B mRNA] CTD PMID:27469509 tributylstannane increases activity ISO RGD:10285 6480464 tributyltin results in increased activity of CAMK2B protein CTD PMID:20810541 tributylstannane multiple interactions ISO RGD:2262 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of CAMK2B mRNA CTD PMID:31129395 tributylstannane decreases expression ISO RGD:2262 6480464 tributyltin results in decreased expression of CAMK2B mRNA CTD PMID:31129395 trichostatin A multiple interactions ISO RGD:2262 6480464 trichostatin A inhibits the reaction [Cisplatin results in decreased expression of CAMK2B mRNA] CTD PMID:23558232 tris(2-chloroethyl) phosphate increases expression ISO RGD:2262 6480464 tris(chloroethyl)phosphate results in increased expression of CAMK2B mRNA, tris(chloroethyl)phosphate results in increased expression of CAMK2B protein CTD PMID:24717766 tungsten decreases expression ISO RGD:10285 6480464 Tungsten results in decreased expression of CAMK2B mRNA CTD PMID:30912803 urethane decreases expression EXP 6480464 Urethane results in decreased expression of CAMK2B mRNA CTD PMID:28818685 valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of CAMK2B gene CTD PMID:29154799 venlafaxine hydrochloride affects expression ISO RGD:2262 6480464 Venlafaxine Hydrochloride affects the expression of CAMK2B mRNA CTD PMID:25423262 vinclozolin multiple interactions ISO RGD:2262 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA CTD PMID:25607892 vinclozolin affects expression ISO RGD:2262 6480464 vinclozolin affects the expression of CAMK2B mRNA CTD PMID:19015723 vitamin E increases expression EXP 6480464 Vitamin E results in increased expression of CAMK2B mRNA CTD PMID:19244175
Gene-Chemical Interaction Annotations
